Open Access
Issue
Med Buccale Chir Buccale
Volume 16, Number 3, juillet 2010
Page(s) 153 - 157
Section Mises au point / Literature reviews
DOI https://doi.org/10.1051/mbcb/2010021
Published online 12 July 2010
  1. Legent F, Narcy P, Beauvillain C, Bordure P. Cancers des voies aérodigestives supérieures : généralités. Masson, Paris, 2003.
  2. Roncin L, Touzalin A, Fleury HJ. Papillomavirus humains et tumeurs des voies aérodigestives supérieures. Lettre Infectiol 2009;24:19-27.
  3. Schechter NR, Gillenwater AM, Byers RM, Garden AS, Morrison WH, Nguyen LN, Podoloff DA, Ang KK. Can positron emission tomography improve the quality of care for head and neck cancer patients ? Int J Radiat Oncol Biol Phys 2001;51:4-9. [PubMed]
  4. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-5. [CrossRef] [PubMed]
  5. Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003;113:888-91. [CrossRef] [PubMed]
  6. Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, Califano J, Cummings CW, Flint PW, Wahl R, Tufano RP. The role of positron emission tomography and computed tomography fusion in the management of early stage and advanced stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:12-6. [CrossRef] [PubMed]
  7. Goerres GW, Schmid DT, Bandhauer F, Huguenin PU, von Schulthess GK, Schmid S, Stoeckli SJ. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105-9. [CrossRef] [PubMed]
  8. Kunkel M, Förster GJ, Reichert TE, Jeong JH, Benz P, Bartenstein P, Wagner W, Whiteside TL. Detection of recurrent oral squamous cell carcinoma by [18F]- 2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 2003;98:2257-65. [CrossRef] [PubMed]
  9. Bourguet P, groupe de travail SOR TEP-FDG. Standards, options, recommandations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract. Bull Cancer 2003;90:567-79.
  10. Ryan WR, Fee WE Jr, Le QT, Pinto HA. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-50. [CrossRef] [PubMed]
  11. Gutzeit A, Antoch G, Kühl H, Egelhof T, Fischer M, Hauth E, Goehde S, Bockisch A, Debatin J, Freudenberg L. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 2005;234:227-34. [CrossRef] [PubMed]
  12. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000;110:1493-7. [CrossRef] [PubMed]
  13. Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004;45:56-68. [PubMed]
  14. Heron DE, Andrade RS, Flickinger J, Johnson J, Agarwala SS, Wu A, Kalnicki S, Avril N. Hybrid PET-CT simulation for radiation treatment planning in head and neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys 2004;60:1419-24. [CrossRef] [PubMed]
  15. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234:879-85. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.